From the Editor-in-Chief
Analysis of big data in cancer medicine will be key to delivering on the cancer moonshot.
by William G. Nelson, MD, PhD
Watching and waiting for cancer to progress can be an alternative to active treatment.
by Kevin McLaughlin
Getting to the Root of Brain Cancer | Determining Value | Cancer Centers Unite to Increase HPV Vaccination Rates | Breast Cancer Survivors and Vaginal Estrogen | PET Scan Overuse | A Report Card on Active Surveillance | Radiation Appointments Are Numerous, And Necessary | Vice President Joe Biden Brings "Moonshot" to AACR Annual Meeting
Your Cancer Guide
Give yourself permission to appreciate your good fortune, despite knowing others who have not fared as well.
by Hester Hill Schnipper
Caregiving With Confidence
Caregiving is difficult, but it can bring rewards.
by Carly O'Brien
Retired Army colonel and prostate cancer survivor Jim Williams asks men to pay better attention to their health.
by Lauren Gravitz
For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
Yesterday & Today
Whether playing Franklin D. Roosevelt or Richard Gilmore, the wealthy scion in 'Gilmore Girls,' Edward Herrmann took on gentlemanly roles that mirrored his real-life persona. He died of brain cancer in 2014.
by Marilyn Fenichel
Bacteria can be friend or foe—or both. Researchers are looking at bacteria to boost the effectiveness of cancer treatments, even if they don't fully understand how the tiny organisms work.
by Stephen Ornes
A Matter of Taste | Bolstering the Brain
Psychiatrist Andrew Roth helps prostate cancer patients identify and take control of their emotions.
by Kate Yandell
Give the gift of music to young cancer patients.
Fran Keilt, Virginia White, Barbara Rascati.
Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
Stock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
An updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
AACR leaders Margaret Foti, PhD, MD (hc), Elizabeth M. Jaffee, MD, and Elaine R. Mardis, PhD, share their stories.
The FDA approves an antihormone agent to treat prostate cancer.
Women who work the night shift may have an increased risk of developing some cancers.
The Financial Toll of Cancer
donate to the AACR